Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Tips from these results
Recent Share tips:
- Avoid Xaar (XAR) by Steve Moore in ShareProphets
- Long Term Buy British Land Company (BLND) by Peter Stephens in The Motley Fool
- Long Term Buy Diageo (DGE) by Peter Stephens in The Motley Fool
- Long Term Buy NATWEST GROUP PLC ORD 100P (NWG) by Peter Stephens in The Motley Fool
- Long Term Buy BP (BP.) by Peter Stephens in The Motley Fool
- Long Term Buy Next (NXT) by Peter Stephens in The Motley Fool
- Sell Powerhouse Energy Group (PHE) by Tom Winnifrith in ShareProphets
- Sell Cyanconnode Holdings (CYAN) by Steve Moore in ShareProphets
- Buy Polar Capital Holdings (POLR) by Andy Ross in The Motley Fool
- Avoid Marks & Spencer Group (MKS) by Andy Ross in The Motley Fool
- Buy Blue Prism Group (PRSM) by Rupert Hargreaves in The Motley Fool
- Long Term Buy Next (NXT) by Nadia Yaqub in The Motley Fool
- Long Term Buy THG (THG) by Nadia Yaqub in The Motley Fool
- Avoid Scottish Mortgage Inv Trust (SMT) by Cliff D'Arcy in The Motley Fool
- Buy Ariana Resources (AAU) by Hot Stock Rockets in ShareProphets
- Buy Whitbread (WTB) by Chris Bailey in ShareProphets
- Buy International Consolidated Airlines Group SA (CDI) (IAG) by Royston Wild in The Motley Fool
- Buy Persimmon (PSN) by Malcolm Stacey in ShareProphets
- Avoid Tesco (TSCO) by Edward Sheldon in The Motley Fool
- Buy TI Fluid Systems (TIFS) by Royston Wild in The Motley Fool
Dechra Pharmaceuticals (DPH)
Health Care Sector
| Latest Bid : – | Latest Ask : – |
| High Today : – | Low Today : – |
| This Years High : – | This Years Low : – |
| Volume : – | MKT Cap : – |
Dechra Pharmaceuticals Overview
Dechra Pharmaceuticals, founded in 1997 following a management buy-out from Lloyds Chemists, develops prescription only veterinary medicines for dogs, cats and horses. Most of its projects involve adapting treatments, currently used by humans, for the animal market. Expertise is in the development, manufacturing and sales and marketing of high quality products exclusively for veterinarians worldwide. It listed in London in 2000.Latest Dechra Pharmaceuticals Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| – | JP Morgan | – | 2020-11-26 10:10:00 26/11/2020 | – |
| – | RBC Capital | – | 2020-11-20 10:00:00 20/11/2020 | – |
| – | Royston Wild | – | 2020-10-24 08:20:00 24/10/2020 | – |
| – | Tom Rodgers | – | 2020-10-22 15:50:00 22/10/2020 | – |
| – | Jefferies | – | 2020-10-21 11:05:00 21/10/2020 | – |
| Latest Bid : – | Latest Ask : – |
| High Today : – | Low Today : – |
| This Years High : – | This Years Low : – |
| Volume : – | MKT Cap : – |
Dechra Pharmaceuticals Overview
Dechra Pharmaceuticals, founded in 1997 following a management buy-out from Lloyds Chemists, develops prescription only veterinary medicines for dogs, cats and horses. Most of its projects involve adapting treatments, currently used by humans, for the animal market. Expertise is in the development, manufacturing and sales and marketing of high quality products exclusively for veterinarians worldwide. It listed in London in 2000.Latest Dechra Pharmaceuticals Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| – | JP Morgan | – | 2020-11-26 10:10:00 26/11/2020 | – |
| – | RBC Capital | – | 2020-11-20 10:00:00 20/11/2020 | – |
| – | Royston Wild | – | 2020-10-24 08:20:00 24/10/2020 | – |
| – | Tom Rodgers | – | 2020-10-22 15:50:00 22/10/2020 | – |
| – | Jefferies | – | 2020-10-21 11:05:00 21/10/2020 | – |